Accuray and RaySearch Forge Collaboration to Enhance Radiation Therapy Technologies
Accuray Incorporated, recognized as a leader in radiation therapy systems that cater to cancer treatments, has formalized a partnership with RaySearch Laboratories AB to enhance adaptive radiation therapy through integrated technologies. This collaboration is aimed at streamlining and personalizing treatment plans for patients, harnessing Accuray's advanced treatment platforms alongside RaySearch's sophisticated treatment planning software, RayStation.
The core goal of this collaboration is to expedite Accuray's adoption of online adaptive radiation therapy. In essence, this technique allows treatment plans to be seamlessly adjusted just before delivery, ensuring they align perfectly with the patient’s current anatomy. Integrating imaging capabilities and treatment planning into a cohesive solution is expected to deliver personalized treatments, ultimately benefiting patient care while enhancing clinical efficiencies.
The immediate focus highlights Accuray's Radixact® platform, with intentions to broaden the solution to include the CyberKnife® platform in the near future. This step represents a significant advancement in cancer treatment technologies, marrying real-time imaging with effective radiation therapy.
Under the newly established agreement, Accuray is set to acquire RayStation licenses amounting to a total order value of around USD $8 million. This significant investment lays the groundwork for marketing the online adaptive radiation therapy solutions collaboratively, signaling a commitment to broadening patient access to advanced treatment options. Additionally, the partnership will capitalize on RayCare® technology, which simplifies system connectivity and streamlines online adaptive workflows within clinical settings.
In continuing collaboration, RaySearch will enhance its software architecture to fully support the Radixact platform. This advancement ensures that healthcare providers can implement a more integrated workflow that facilitates online adaptive radiation therapy seamlessly.
"Advanced software is a key enabler of online adaptive radiation therapy," stated Johan Löf, founder and CEO of RaySearch. He emphasized that by melding RayStation and RayCare technologies with Accuray’s imaging and treatment delivery capabilities, a more comprehensive solution could be developed, which is crucial for easing clinic implementations of adaptive radiation therapy.
Steve LaNeve, CEO of Accuray, added, "Strategic partnerships are instrumental to our growth trajectory, enabling us to fuel innovation while honing our core competencies. The expertise of RaySearch in treatment planning and system integration makes them an invaluable ally as we advance our online adaptive therapy initiatives. Together, we aim to deliver personalized and efficient treatments to patients on a global scale."
Accuray remains committed to pioneering advancements in radiation therapy to significantly enhance patient outcomes. The company emphasizes its dedication to innovation, aiming to tackle even the most intricate cases while simultaneously simplifying the approach towards conventional treatments. With its corporate headquarters in Madison, Wisconsin, and operations around the world, Accuray collaborates closely with healthcare professionals to optimize treatment delivery and patient recovery.
Founded in 2000 as a spin-off from the prestigious Karolinska Institute in Stockholm, RaySearch Laboratories specializes in creating groundbreaking medical software solutions that enhance cancer treatments. Their flagship products include the RayStation® treatment planning system and the RayCare® oncology information system, which serve over 1,200 clinics across 54 countries.
The collaborative efforts of Accuray and RaySearch set the stage for innovative advancements in the field of oncology, promising more effective and adaptive radiation therapy solutions for patients worldwide. By pooling resources and expertise, both companies are not only paving the way for enhanced treatments but are also reinforcing their positions as market leaders in cancer care technology.
Overview of the Collaboration
The core goal of this collaboration is to expedite Accuray's adoption of online adaptive radiation therapy. In essence, this technique allows treatment plans to be seamlessly adjusted just before delivery, ensuring they align perfectly with the patient’s current anatomy. Integrating imaging capabilities and treatment planning into a cohesive solution is expected to deliver personalized treatments, ultimately benefiting patient care while enhancing clinical efficiencies.
The immediate focus highlights Accuray's Radixact® platform, with intentions to broaden the solution to include the CyberKnife® platform in the near future. This step represents a significant advancement in cancer treatment technologies, marrying real-time imaging with effective radiation therapy.
Financial and Technical Aspects
Under the newly established agreement, Accuray is set to acquire RayStation licenses amounting to a total order value of around USD $8 million. This significant investment lays the groundwork for marketing the online adaptive radiation therapy solutions collaboratively, signaling a commitment to broadening patient access to advanced treatment options. Additionally, the partnership will capitalize on RayCare® technology, which simplifies system connectivity and streamlines online adaptive workflows within clinical settings.
In continuing collaboration, RaySearch will enhance its software architecture to fully support the Radixact platform. This advancement ensures that healthcare providers can implement a more integrated workflow that facilitates online adaptive radiation therapy seamlessly.
Industry Insights and Quotes
"Advanced software is a key enabler of online adaptive radiation therapy," stated Johan Löf, founder and CEO of RaySearch. He emphasized that by melding RayStation and RayCare technologies with Accuray’s imaging and treatment delivery capabilities, a more comprehensive solution could be developed, which is crucial for easing clinic implementations of adaptive radiation therapy.
Steve LaNeve, CEO of Accuray, added, "Strategic partnerships are instrumental to our growth trajectory, enabling us to fuel innovation while honing our core competencies. The expertise of RaySearch in treatment planning and system integration makes them an invaluable ally as we advance our online adaptive therapy initiatives. Together, we aim to deliver personalized and efficient treatments to patients on a global scale."
About Accuray
Accuray remains committed to pioneering advancements in radiation therapy to significantly enhance patient outcomes. The company emphasizes its dedication to innovation, aiming to tackle even the most intricate cases while simultaneously simplifying the approach towards conventional treatments. With its corporate headquarters in Madison, Wisconsin, and operations around the world, Accuray collaborates closely with healthcare professionals to optimize treatment delivery and patient recovery.
About RaySearch
Founded in 2000 as a spin-off from the prestigious Karolinska Institute in Stockholm, RaySearch Laboratories specializes in creating groundbreaking medical software solutions that enhance cancer treatments. Their flagship products include the RayStation® treatment planning system and the RayCare® oncology information system, which serve over 1,200 clinics across 54 countries.
Future Outlook
The collaborative efforts of Accuray and RaySearch set the stage for innovative advancements in the field of oncology, promising more effective and adaptive radiation therapy solutions for patients worldwide. By pooling resources and expertise, both companies are not only paving the way for enhanced treatments but are also reinforcing their positions as market leaders in cancer care technology.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.